JP2023525757A5 - - Google Patents
Info
- Publication number
- JP2023525757A5 JP2023525757A5 JP2022567882A JP2022567882A JP2023525757A5 JP 2023525757 A5 JP2023525757 A5 JP 2023525757A5 JP 2022567882 A JP2022567882 A JP 2022567882A JP 2022567882 A JP2022567882 A JP 2022567882A JP 2023525757 A5 JP2023525757 A5 JP 2023525757A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- independently
- alkyl
- case
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022111P | 2020-05-08 | 2020-05-08 | |
| US63/022,111 | 2020-05-08 | ||
| US202063120984P | 2020-12-03 | 2020-12-03 | |
| US63/120,984 | 2020-12-03 | ||
| PCT/US2021/031381 WO2021226517A1 (en) | 2020-05-08 | 2021-05-07 | Akt3 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525757A JP2023525757A (ja) | 2023-06-19 |
| JP2023525757A5 true JP2023525757A5 (cg-RX-API-DMAC10.html) | 2024-05-16 |
Family
ID=78468495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567882A Pending JP2023525757A (ja) | 2020-05-08 | 2021-05-07 | Akt3モジュレーター |
Country Status (12)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
| WO2021226477A1 (en) * | 2020-05-08 | 2021-11-11 | Georgiamune Llc | Akt3 modulators |
| IL312439A (en) * | 2021-11-05 | 2024-06-01 | Georgiamune Inc | Akt3 modulators |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69939168D1 (de) * | 1998-05-26 | 2008-09-04 | Warner Lambert Co | Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung |
| MXPA06010667A (es) * | 2004-03-19 | 2007-07-04 | Penn State Res Found | Metodos combinatorios y composiciones para el tratamiento de melanoma. |
| FR2884516B1 (fr) * | 2005-04-15 | 2007-06-22 | Cerep Sa | Antagonistes npy, preparation et utilisations |
| WO2007076474A1 (en) * | 2005-12-23 | 2007-07-05 | Kalypsys, Inc. | Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| EP2078008A2 (en) * | 2006-10-12 | 2009-07-15 | SuperGen, Inc. | Quinoline derivatives for modulating dna methylation |
| US7790746B2 (en) * | 2007-10-12 | 2010-09-07 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| JP5746015B2 (ja) * | 2008-04-16 | 2015-07-08 | マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー | Axlキナーゼ阻害剤としてのキノリン誘導体 |
| BR112012011328A2 (pt) * | 2009-10-23 | 2016-11-22 | Lilly Co Eli | inibidores de akt |
| FR2972535B1 (fr) * | 2011-03-07 | 2014-05-02 | Crime Scene Technology | Trousse de revelation comprenant une tetrazine et un cyanoacrylate, procede de co-fumigation d'une tetrazine et d'un cyanoacrylate |
| CN102775389B (zh) * | 2012-04-05 | 2014-12-17 | 华侨大学 | N-取代-4-(7-氯喹啉-4-氨基)-苯甲酰胺衍生物的制备方法和应用 |
| CN102659628B (zh) * | 2012-04-26 | 2014-07-02 | 四川大学 | 含芳酰胺的邻苯二甲腈单体及其合成方法和用其固化制备的聚邻苯二甲腈树脂 |
| EP2875014B1 (en) * | 2012-07-17 | 2017-11-29 | Washington University | Anti-mucus drugs and uses therefor |
| WO2017039318A1 (en) * | 2015-09-01 | 2017-03-09 | Kainos Medicine, Inc. | Benzimidazole derivatives for dna methylation inhibitors |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| US10342868B2 (en) * | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| US10519113B2 (en) * | 2016-08-17 | 2019-12-31 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds, compositions, and methods of treating cancer |
| CN106749071B (zh) * | 2017-01-10 | 2019-03-01 | 江西师范大学 | 一种芳香类1,2,4,5-四嗪化合物的制备方法 |
| EP3678666B1 (en) * | 2017-09-07 | 2025-07-09 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
| US20210213014A1 (en) * | 2017-10-18 | 2021-07-15 | Epizyme, Inc. | Methods of using ehmt2 inhibitors in immunotherapies |
| BR112022022327A2 (pt) * | 2020-05-08 | 2023-01-03 | Georgiamune Llc | Moduladores de akt3 e métodos de uso dos mesmos |
| CN114181199B (zh) * | 2020-09-15 | 2023-09-26 | 成都赜灵生物医药科技有限公司 | 2,4-二取代嘧啶衍生物及其制备方法和用途 |
-
2021
- 2021-05-07 US US17/923,837 patent/US20230295114A1/en active Pending
- 2021-05-07 MX MX2022014020A patent/MX2022014020A/es unknown
- 2021-05-07 AU AU2021268210A patent/AU2021268210A1/en active Pending
- 2021-05-07 CA CA3182673A patent/CA3182673A1/en active Pending
- 2021-05-07 CN CN202180046207.0A patent/CN115996939A/zh active Pending
- 2021-05-07 IL IL297598A patent/IL297598A/en unknown
- 2021-05-07 BR BR112022022342A patent/BR112022022342A2/pt unknown
- 2021-05-07 EP EP21800647.6A patent/EP4146666A4/en active Pending
- 2021-05-07 JP JP2022567882A patent/JP2023525757A/ja active Pending
- 2021-05-07 WO PCT/US2021/031381 patent/WO2021226517A1/en not_active Ceased
- 2021-05-07 PH PH1/2022/553031A patent/PH12022553031A1/en unknown
- 2021-05-07 KR KR1020227042289A patent/KR20230022456A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524596A5 (cg-RX-API-DMAC10.html) | ||
| JP2023524600A5 (cg-RX-API-DMAC10.html) | ||
| JP6898327B2 (ja) | 新規化合物 | |
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| CZ297907B6 (cs) | Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem | |
| JP2024541995A5 (cg-RX-API-DMAC10.html) | ||
| AU2018360850A1 (en) | Modulators of the integrated stress pathway | |
| CA3080808A1 (en) | Modulators of the integrated stress pathway | |
| CZ20022014A3 (cs) | Aminothiazolové inhibitory na cyklin-dependentních kinas | |
| JP2024540107A5 (cg-RX-API-DMAC10.html) | ||
| JP2017520571A5 (cg-RX-API-DMAC10.html) | ||
| JP2014510774A5 (cg-RX-API-DMAC10.html) | ||
| RU2011108024A (ru) | 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов | |
| MX2009001036A (es) | Pirazolopirimidinas, proceso para su preparacion y su uso como medicina. | |
| JP2014506892A5 (cg-RX-API-DMAC10.html) | ||
| JP2017532360A5 (cg-RX-API-DMAC10.html) | ||
| JP2021535112A5 (cg-RX-API-DMAC10.html) | ||
| CY1111316T1 (el) | Νεα παραγωγα 5-υποκατεστημενο 7-αμινο-[1,3]θειαζολο[4,5-d] πυριμιδινης | |
| JP2023525756A5 (cg-RX-API-DMAC10.html) | ||
| RU2010140613A (ru) | Амиды диазабициклоалканов, селективные в отношении подтипа никотиновых ацетилхолиновых рецепторов | |
| US20190202826A1 (en) | Phosphotidylinositol 3-Kinase Inhibitors | |
| JP2024541994A5 (cg-RX-API-DMAC10.html) | ||
| JP2024541975A5 (cg-RX-API-DMAC10.html) | ||
| JP2023525757A (ja) | Akt3モジュレーター |